Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-Associated Myocarditis

作     者：Yan WANG Huiyong CHEN Jinyi LIN Jiahui CHEN Yuhong ZHOU Yingmei ZHANG Hongwei ZHANG Wei ZHU Jie HU Gang ZHAO Xiangdong YANG Shisuo DU Xiaoyu LI Guoming SHI Jie CUI Wei WU Jing LI Chi ZHANG Cong WANG Rongle LIU Zheng LI Chunhui WANG Leilei CHENG Junbo GE 

作者机构：Department of Medical OncologyZhongshan HospitalFudan UniversityShanghaiChina Department of Rheumatology and ImmunologyZhongshan HospitalFudan UniversityShanghaiChina Department of CardiologyZhongshan HospitalFudan UniversityShanghaiChina Department of General SurgeryZhongshan HospitalFudan UniversityShanghaiChina Pneumology DepartmentZhongshan HospitalFudan UniversityShanghaiChina Central Laboratory of Shanghai Institute of Cardiovascular DiseasesChina Department of RadiotherapyZhongshan HospitalFudan UniversityShanghaiChina Department of PharmacyZhongshan HospitalFudan UniversityShanghaiChina Department of Hepatic OncologyZhongshan HospitalFudan UniversityShanghaiChina Department of Cardiac UltrasoundZhongshan HospitalFudan UniversityShanghaiChina National Clinical Research Center for Interventional MedicineShanghaiChina Shanghai Institute of Cardiovascular DiseasesChina Shanghai Institute of Imaging MedicineChina 

出 版 物：《Clinical Cancer Bulletin》 (临床癌症通报（英文）)

年 卷 期：2022年第1卷第3期

页      面：123-143页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Immune checkpoint inhibitor myocarditis cardiotoxicity immune-related adverse reactions 

摘      要：Immune checkpoint inhibitors(ICIs)are often beneficial in the treatment of multiple types of malignant ***,ICI-associated myocarditis has introduced new clinical *** report highlights the key clinical issues of ICI-associated myocarditis,such as risk factors,diagnosis and differential diagnosis,clinical classification and treatment,monitoring of outcomes,and restart of ***,practical guidance and suggestions for the diagnosis and treatment of ICI-associated myocarditis are proposed with reference to the relevant consensuses or guidelines and newly published evidence-based studies in China and other countries in combination with clinical experience of physicians from Shanghai,China.